“…This is supported by Pls-deficient mouse, which revealed severe phenotypic alterations, including defects in CNS myelination (Gorgas et al, 2006). In addition to peroxisomal disorders, decreased brain Pls content has been reported in a number of neurological disorders such as spinal cord injury, Alzheimer's disease, Down syndrome, and multiple sclerosis (Lessig & Fuchs, 2009). The final step of PlsEtn biosynthesis is the desaturation of 1-alkyl-2-acyl-GPE via the action of Δ1 desaturase, whereas PlsCho is primarily formed from PlsEtn via polarhead group modification, by which mechanism remains still obscure (Lee, 1998).…”